Bayesian Capital Management’s ZENDESK INC ZEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-38,067
Closed -$2.9M 1109
2022
Q3
$2.9M Buy
+38,067
New +$2.89M 0.59% 29
2021
Q3
Sell
-4,900
Closed -$707K 595
2021
Q2
$707K Buy
+4,900
New +$692K 0.18% 140
2020
Q3
Sell
-5,292
Closed -$469K 746
2020
Q2
$469K Sell
5,292
-5,779
-52% -$445K 0.1% 246
2020
Q1
$709K Buy
+11,071
New +$864K 0.15% 203
2019
Q3
Sell
-18,071
Closed -$1.61M 739
2019
Q2
$1.61M Sell
18,071
-4,300
-19% -$370K 0.33% 81
2019
Q1
$1.9M Sell
22,371
-5,100
-19% -$374K 0.37% 78
2018
Q4
$1.6M Sell
27,471
-503
-2% -$29K 0.33% 65
2018
Q3
$1.99M Buy
27,974
+5,300
+23% +$338K 0.33% 73
2018
Q2
$1.24M Buy
22,674
+500
+2% +$26.6K 0.28% 91
2018
Q1
$1.06M Sell
22,174
-6,700
-23% -$278K 0.27% 110
2017
Q4
$977K Buy
+28,874
New +$945K 0.2% 175
2017
Q2
Sell
-25,700
Closed -$721K 638
2017
Q1
$721K Buy
+25,700
New +$665K 0.34% 85
2016
Q3
Sell
-16,400
Closed -$433K 550
2016
Q2
$433K Buy
+16,400
New +$396K 0.26% 143
2016
Q1
Sell
-8,722
Closed -$231K 461
2015
Q4
$231K Buy
+8,722
New +$204K 0.33% 148

Other funds holding ZEN

Bayesian Capital Management's ZEN Position: Q4 2022 in Review

Bayesian Capital Management sold out of ZENDESK INC (ZEN) in Q4 2022, closing a stake of 38,067 shares — an estimated $2.9M sold.

Bayesian Capital Management first reported a position in ZEN in Q4 2015 and held it in 14 quarters. The position peaked at $2.9M in Q3 2022. 3 funds tracked by Wall St. Rank hold ZEN as of Q4 2022.

  • Bayesian Capital Management reported no remaining ZENDESK INC position as of Q4 2022 after selling out during the quarter.
  • Bayesian Capital Management sold 38,067 ZENDESK INC shares in Q4 2022, an estimated $2.9M.
  • Bayesian Capital Management first reported a position in ZENDESK INC in Q4 2015 and held it in 14 quarters.
  • Bayesian Capital Management's ZENDESK INC position peaked at $2.9M in Q3 2022.
  • 3 funds tracked by Wall St. Rank held ZENDESK INC as of Q4 2022.

Based on Bayesian Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.